CompletedNCT00036582
Clozapine for young people with treatment-resistant bipolarity
About this title
Clozapine vs. Placebo in Treatment-Refractory Bipolar Disorder in Children and Adolescents
Read the official source — NCT00036582Medication studyUnited States
Understand this study
- Listed locations
- BethesdaSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateMay 2002
- Recruitment status
- Completed
- Enrollment listed in the registry
- 116
- Sponsor
- National Institute of Mental Health (NIMH)
- Sponsor type
- Government agency
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- Not clearly listed
- Official registry ID
- NCT00036582
- Official title
Show the full official title
Clozapine vs Placebo In Treatment-Refractory Bipolar Disorder In Children And Adolescents
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Bethesda
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is National Institute of Mental Health (NIMH), a government agency.
Did this study involve medication?
Yes. The study involved medication, including Clozapine.
